A new nanoconjugate blocks acute myeloid leukaemia tumour cells without harming healthy ones
Acute myeloid leukaemia (AML) is a heterogeneous disease which usual treatment is very aggressive and…
Acute myeloid leukaemia (AML) is a heterogeneous disease which usual treatment is very aggressive and…